A Comparison of Clinical Characteristics in Overweight/Obese and Normal Weight Patients with Psoriasis Vulgaris: A Bicentric Retrospective Observational Study
Lanzhi Li,Keshuai Liu,Xingwu Duan,Limei Xu,Qingqi Yang,Fang Liu
DOI: https://doi.org/10.2147/CCID.S411636
2023-05-30
Abstract:Lanzhi Li, 1, &ast Keshuai Liu, 1, &ast Xingwu Duan, 1 Limei Xu, 2 Qingqi Yang, 2 Fang Liu 2 1 Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 2 Department of Dermatology, Air Force Medical Center of PLA, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xingwu Duan, Email Background: Psoriasis is a chronic, inflammatory skin disease that is often accompanied by multiple comorbidities. Obesity is considered an independent risk factor for the development of psoriasis. However, most of the related data are derived from epidemiological studies conducted in the United States of America and Europe. This study aimed to compare the clinical characteristics of patients with psoriasis who are overweight/obese and patients with psoriasis with normal weight in China. Methods: We reviewed the medical records of 208 patients with psoriasis. Based on their body mass index (BMI), the patients were divided into two groups: patients with psoriasis who were overweight/obese and patients with psoriasis with normal weight. Results: The most patients enrolled in this study were men (77.40%). Patients with psoriasis who were overweight/obese had a higher mean age, longer disease duration, and significantly higher Psoriasis Area and Severity Index (PASI) values ( P =0.032). Additionally, the incidence of fatty liver, hyperlipidemia, hyperuricemia, and abnormal liver function was higher among patients with psoriasis who were overweight/obese ( P < 0.05). Linear regression analysis revealed a linear relationship between PASI values and BMI ( P =0.016). Moreover, patients with psoriasis who were overweight/obese had significantly higher levels of serum alanine transaminase (ALT), aspartate transaminase (AST), uric acid (UC), total cholesterol (TC), low-density lipoprotein (LDL), and fasting plasma glucose (FPG) ( P < 0.05) and lower serum high-density lipoprotein (HDL) levels and absolute lymphocyte count (ALC) ( P < 0.05). Conclusion: Patients with psoriasis who are overweight/obese have more severe psoriatic lesions and metabolic comorbidities. Detailed assessment of the BMI of patients with psoriasis revealed that weight loss may be necessary for patients who are overweight/obese to reduce the risk of metabolic disorders. Keywords: psoriasis, obesity, metabolic disorders Psoriasis vulgaris is a chronic, inflammatory skin disease characterized by abnormal proliferation and differentiation of keratinocytes. Recent studies have demonstrated that psoriasis vulgaris is associated with comorbidities including cardiovascular disease, obesity, type 2 diabetes mellitus (T2DM), and nonalcoholic fatty liver disease (NAFLD). 1,2 As one of the important comorbidities, obesity is considered an independent risk factor for the onset of psoriasis vulgaris. 3 With an increase in body mass index (BMI), the prevalence of psoriasis also increases. 4,5 A study from the UK and Norway showed that for every 1 kg/m 2 increase in BMI in patients with obesity, the incidence of psoriasis increases by 4%. 4 Another retrospective study involving 1.5 million people reported that the incidence of psoriasis was significantly higher in individuals with obesity than in individuals with normal weight and increased with an increase in weight. 5 Obesity not only worsens the clinical outcome of psoriasis but also increases the likelihood of developing adverse events, such as delayed response to biological therapy 6 and increased risk of hyperlipidemia during treatment with methotrexate and acitretin. 7,8 However, weight loss could reduce the severity of skin lesions and improve the quality of life of patients with psoriasis. 9–13 At present, studies investigating the clinical characteristics of patients with psoriasis who are overweight/obese are lacking. 4,5,14,15 Although relevant information is available in several related studies, most data are derived from epidemiological studies conducted in Europe and the USA. 16,17 Therefore, this study aimed to investigate the clinical characteristics of Chinese patients with psoriasis to elucidate the relationship between psoriasis and obesity. This study conformed to the ethical guidelines of the Declaration of Helsinki. The Ethics Committee of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine approved the research (Registration number:2022DZMEC-494-01). Patient consent is not required for this retrospective study. We -Abstract Truncated-
dermatology